Ratziu, V. Et Al. 2025. Aramchol improves hepatic fibrosis in metabolic dysfunction-associated steatohepatitis: Results of multimodality assessment using both conventional and digital pathology. Hepatology , vol.81, no.3 , 932-946.

Ratziu, V., Yilmaz, Y., Lazas, D., Friedman, S. L., Lackner, C., Behling, C., ... Cummings, O. W.(2025). Aramchol improves hepatic fibrosis in metabolic dysfunction-associated steatohepatitis: Results of multimodality assessment using both conventional and digital pathology. Hepatology , vol.81, no.3, 932-946.

Ratziu, Vlad Et Al. "Aramchol improves hepatic fibrosis in metabolic dysfunction-associated steatohepatitis: Results of multimodality assessment using both conventional and digital pathology," Hepatology , vol.81, no.3, 932-946, 2025

Ratziu, Vlad Et Al. "Aramchol improves hepatic fibrosis in metabolic dysfunction-associated steatohepatitis: Results of multimodality assessment using both conventional and digital pathology." Hepatology , vol.81, no.3, pp.932-946, 2025

Ratziu, V. Et Al. (2025) . "Aramchol improves hepatic fibrosis in metabolic dysfunction-associated steatohepatitis: Results of multimodality assessment using both conventional and digital pathology." Hepatology , vol.81, no.3, pp.932-946.

@article{article, author={Vlad Ratziu Et Al. }, title={Aramchol improves hepatic fibrosis in metabolic dysfunction-associated steatohepatitis: Results of multimodality assessment using both conventional and digital pathology}, journal={Hepatology}, year=2025, pages={932-946} }